For the Inventor, By the Inventor

Enter assignee name

Kinki University

USPTO Granted Patents = 55

% Expired Patents = 36.4

EPO Patents = 27

Trademarks = 2

Forward Citations = 48

Loading Chart...

Loading Chart...

152 inventors (with patents filed for the assignee):

Atsufumi Kawabata (6 out of 8 patents)

Kazuhiko Nakagawa (5 out of 6 patents)

Tamio Ida (4 out of 4 patents)

4. Kimio Yonesaka (4 out of 4 patents)

5. Shunji Ishiwata (3 out of 4 patents)

6. Atsushi Taga (3 out of 4 patents)

7. Hiroyuki Nishikawa (3 out of 8 patents)

8. Osamu Muraoka (3 out of 3 patents)

9. Shigeki Hontsu (3 out of 3 patents)

10. Hiroaki Nishikawa (3 out of 3 patents)

11. Masanobu Kusunoki (3 out of 3 patents)

12. Takeharu Etoh (3 out of 14 patents)

13. Hiroto Tanaka (2 out of 4 patents)

14. Toru Ogawa (2 out of 3 patents)

15. Kenji Hirotani (2 out of 3 patents)

Core Competencies:

Cancer Cell Growth Inhibition

Ocular Surface Drug Retention

Intervertebral Disc Degeneration

Biomarker Selection

Peripheral Sensory Neuropathy

T-Type Calcium Channel Inhibition

Nanoparticle Production

Anticancer Agent Degradation

Hard Tissue Regeneration

Friction Stir Processing

Biocompatible Transparent Sheets

Chemical Sensor Devices

55 patents: Sort by Forward Citations

1. 12715842 - D-luciferin, D-luciferin derivative, precursor of these compounds and method for producing these compounds (2026-08-25),

2. 12667557 - METHOD FOR TREATING EGFR-TKI-RESISTANT NON-SMALL CELL LUNG CANCER BY ADMINISTRATION OF ANTI-HER3 ANTIBODY-DRUG CONJUGATE (2026-06-30),

3. 12636310 - Therapeutic agent for short tear breakup time-type dry eye and eye drops containing same (2026-05-26),

4. 12583938 - Protein biomarker and uses thereof (2026-03-24),

5. 12582369 - Mammography apparatus (2026-03-24),

6. 12338198 - Cancer cell growth inhibiting composition and processed food (2025-06-24),

7. 12102713 - Ocular surface drug retention agent, eye drop containing the same, and method for retention of ocular surface drug using the same and method for treating ocular disease (2024-10-01),

8. 11951231 - Therapeutic agent for intervertebral disc degeneration and material for culturing inter vertebral disc cells (2024-04-09),

9. 11879150 - Treatment selection method and biomarker indicating selection (2024-01-23),

10. 11873344 - Protein biomarker and uses thereof (2024-01-16),

11. 11793845 - Composition for ameliorating peripheral sensory neuropathy (2023-10-24),

12. 11479537 - T-type calcium channel inhibitor (2022-10-25),

13. 11446608 - Method for reducing HTO concentration in aqueous solution (2022-09-20),

14. 11432552 - Deodorizing/antibacterial agent (2022-09-06),

15. 11420944 - Voltage-dependent t-type calcium channel blocker (2022-08-23),

Kinki University, located in Japan, is a prestigious higher education institution offering a wide range of academic programs. With a history of over 70 years, Kinki University is dedicated to providing quality education and fostering academic excellence. The university's website provides comprehensive information about its faculties, research centers, admission process, and various academic resources available to students. Visit Kinki University's website to explore the opportunities and experience the academic atmosphere offered by this esteemed institution.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Kinki University

55 Patents

#177 in Osaka

#1,617 in Japan

#12,881 in the World

Kinki University

Forward Citations = 48

152 inventors:

Atsufumi Kawabata (6 out of 8 patents)

Kazuhiko Nakagawa (5 out of 6 patents)

Tamio Ida (4 out of 4 patents)

4. Kimio Yonesaka (4 out of 4 patents)

5. Shunji Ishiwata (3 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…